The safety of voriconazole

被引:66
作者
Potoski, BA [1 ]
Brown, J [1 ]
机构
[1] Ohio State Univ, Med Ctr, Dept Pharm, Columbus, OH 43210 USA
关键词
D O I
10.1086/343746
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1273 / 1275
页数:3
相关论文
共 9 条
  • [1] A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients
    Ally, R
    Schürmann, D
    Kreisel, W
    Carosi, G
    Aguirrebengoa, K
    Dupont, B
    Hodges, M
    Troke, P
    Romero, AJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (09) : 1447 - 1454
  • [2] BAUER LA, 2002, PHARMACOTHERAPY PATH, P40
  • [3] Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
    Denning, DW
    Ribaud, P
    Milpied, N
    Caillot, D
    Herbrecht, R
    Thiel, E
    Haas, A
    Ruhnke, M
    Lode, H
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) : 563 - 571
  • [4] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
    Herbrecht, R
    Denning, DW
    Patterson, TF
    Bennett, JE
    Greene, RE
    Oestmann, JW
    Kern, WV
    Marr, KA
    Ribaud, P
    Lortholary, O
    Sylvester, R
    Rubin, RH
    Wingard, JR
    Stark, P
    Durand, C
    Caillot, D
    Thiel, E
    Chandrasekar, PH
    Hodges, MR
    Schlamm, HT
    Troke, PF
    de Pauw, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) : 408 - 415
  • [5] Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: A dose escalation study
    Lazarus, HM
    Blumer, JL
    Yanovich, S
    Schlamm, H
    Romero, A
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (04) : 395 - 402
  • [6] PATTERSON BE, 1995, 35 INT C ANT AG CHEM, P126
  • [7] Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients
    Romero, AJ
    Le Pogamp, P
    Nilsson, LG
    Wood, N
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (04) : 226 - 234
  • [8] Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
    Walsh, TJ
    Lutsar, I
    Driscoll, T
    Dupont, B
    Roden, M
    Ghahramani, P
    Hodges, M
    Groll, AH
    Perfect, JR
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (03) : 240 - 248
  • [9] Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh, TJ
    Pappas, P
    Winston, DJ
    Lazarus, HM
    Petersen, F
    Raffalli, J
    Yanovich, S
    Stiff, P
    Greenberg, R
    Donowitz, G
    Lee, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) : 225 - 234